CAS: 941685-37-6 - Incb 18424

Formel: C₁₇H₁₈N₆

InChl: InChI=1S/C17H18N6/c18-7-5-15(12-3-1-2-4-12)23-10-13(9-22-23)16-14-6-8-19-17(14)21-11-20-16/h6,8-12,15H,1-5H2,(H,19,20,21)/t15-/m0/s1

InChI Key: InChIKey=HFNKQEVNSGCOJV-HNNXBMFYSA-N

SMILES: N#CCC(N1N=CC(=C1)C=2N=CN=C3NC=CC32)C4CCCC4

1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (βS)-

CAS: 941685-37-6

• Formel: C₁₇H₁₈N₆
• Reinheit: 98%
• Farbe und Form: Solid
• Molekulargewicht: 306.3650

(S)-Ruxolitinib

CAS: 2703484-89-1 941685-37-6

• Formel: C₁₇H₁₈N₆
• Farbe und Form: White To Off-White Solid
• Molekulargewicht: 306.37

Ruxolitinib (S enantiomer)

CAS: 941685-37-6

Ruxolitinib S enantiomer (INCB18424) is the S-enantiomer of Ruxolitinib. Ruxolitinib is the first potent, selective …

• Formel: C₁₇H₁₈N₆
• Reinheit: 99.5% - 99.79%
• Farbe und Form: Solid
• Molekulargewicht: 306.36

(3S)-3-Cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile (ent-Ruxolitinib)

CAS: 941685-37-6

Applications (3S)-3-Cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile is a newly developed JAK2 inhibitor therapy aimed to improve MPN-associated splenomegaly and …

• Formel: C₁₇H₁₈N₆
• Farbe und Form: Neat
• Molekulargewicht: 306.36

S-Ruxolitinib (INCB018424)

CAS: 941685-37-6

Ruxolitinib is a janus tyrosine kinase inhibitor active specifically on sub-types JAK1 and JAK2 with …

• Formel: C₁₇H₁₈N₆
• Reinheit: Min. 95%
• Molekulargewicht: 306.37 g/mol